Arab World vs Latvia: Cause of death, by non-communicable diseases, male
Arab World
53.7%
in 2021
Latvia
78.6%
in 2021
Arab World rank
24th
Latvia rank
27th
Cause of death, by non-communicable diseases, male over time
- Arab World
- Latvia
How they compare
Latvia currently reports 78.6% against 53.7% in Arab World, a difference of 24.9%.
That makes Latvia's figure about 1.5 times Arab World's.
Across all 6 years both countries report, Latvia has been ahead every year.
Arab World ranks 24th and Latvia ranks 27th of 47 groups.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Arab World | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.8% | 79.8% | 26.1% | Latvia |
| 2010s | 61.5% | 87.6% | 26.1% | Latvia |
| 2020s | 56.0% | 82.7% | 26.7% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Arab World or Latvia?
- Latvia, at 78.6% against 53.7% in Arab World as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Arab World and Latvia?
- 24.9%, with Latvia ahead.
- How many years of comparable data are there for Arab World and Latvia?
- 6 years are reported by both, from 2000 to 2021.
- How do Arab World and Latvia rank globally for cause of death, by non-communicable diseases, male?
- Arab World ranks 24th and Latvia ranks 27th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.